The British pharma and consumer giant’s stock was on a rising trajectory till the announcement of third-quarter results on Oct 25. On the call, Glaxo expressed …
Acceleron Pharma Inc. (XLRN) has priced an underwritten public offering of 5.40 million shares of common stock at a price of $37.00 each ... LPCN closed Wednesday's trading at $4.00, up 1.78%. Pfizer (PFE) has filed a suit against Johnson …
On Monday, Pfizer’s shares in New York closed up 0.21 percent. Year-to-date, the company’s stock has remained flat, slightly underperforming the broader market index.
Pfizer Inc.(NYSE:PFE) On Friday afternoon, the stock of Pfizer dropped about 1% in a second. The flash crash type move, albeit shallow, included all exchanges and the price quickly regained all losses. This past week Nanex published a …
Pfizer Inc (NYSE:PFE) has potential upside of 11.3% based on a current price of $33.40 and analysts' consensus price target of $37.18. The stock should discover initial support at its 200-day moving average (MA) of $32.28 and subsequent …
Pfizer PFE is one of the largest pharmaceutical companies out there. With a market cap above $200 billion, many may think that the company doesn’t have much more room to grow its share price, but what’s not to love? The company has …
Pete Najarian is long stock AAPL, BAC, BKE, CMCSA, CSX, DIS, FGP, GM, HAL, IBM, KO, MLCO, MRK, MSFT, MU, NKE, NTRS, PEP, PFE, SNBR, TPX, TRN, UPS, VIAB, WDC, WFC, WYNN. Pete owns TLT puts. Bought IBM, …
In after hours trade shares of Pfizer were up 1.4% following the announcement. Pfizer is set to announce third quarter results on Tuesday, October 28 before the market open. Get the latest Pfizer stock price here.
Pfizer Inc. (NYSE: PFE) shareholders have experienced the short-term euphoria of seeing their stock rally a massive 10 percent from August to September. The stock failed to eclipse key “triple threat” resistance (created by a horizontal line ...
This video takes a closer look at three top blue chip companies which may be in focus for investors this earnings season. After all, with recent risks to the market, investors have been focusing more on blue chips and large caps in general, …